| Sentence | Level | |----------|-------| | Scientists are currently testing nilotinib to treat other types of cancer | C1 | | A comparison of nilotinib and imatinib in the treatment of imatinib-resistant or intolerant choriocarcinoma within the NCRI| B2 |
Adjective
| Sentence | Level | |----------|-------| | Pilocytic astrocytomas and other low-grade gliomas may be responsive to nilotinib | C1 | | Nilotinib improves the progression-free survival of patients with imatinib-resistant gastrointestinal stromal tumors| B2 |